BREAKING NEWS: Report: Sanofi approaches Genzyme with buyout deal
This is a discussion on BREAKING NEWS: Report: Sanofi approaches Genzyme with buyout deal within the Biotechnology News forum, part of the Industry News and Updates category; Sanofi-Aventis ( NYSE: SNY ) has approached Genzyme ( NASDAQ: GENZ ) regarding a potential buyout deal, causing the beleaguered biotech's stock ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
07-23-2010, 04:25 PM
|
|||
|
|||
BREAKING NEWS: Report: Sanofi approaches Genzyme with buyout deal
Sanofi-Aventis (NYSE: SNY) has approached Genzyme (NASDAQ: GENZ) regarding a potential buyout deal, causing the beleaguered biotech's stock to surge Friday afternoon. Citing people familiar with the matter, the Wall Street Journal reports the two sides are in the early stages of assessing each other's interest in the deal, including the appropriate price for Genzyme. The rare disease company has a market cap of $13 billion. Read more...
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| BREAKING NEWS: Pfizer dumps about 100 drug development programs | industry_news | Biotechnology News | 0 | 01-27-2010 03:07 PM |
| BREAKING NEWS: Novartis takes lead position in race for swine flu vax | industry_news | Biotechnology News | 0 | 06-12-2009 10:10 AM |
| Report: Genentech and Roche near $46.7B deal | industry_news | Biotechnology News | 0 | 03-10-2009 12:30 PM |
| Sanofi lining up billions for a major buyout | industry_news | Biotechnology News | 0 | 02-02-2009 12:30 PM |
| Earlier and More Aggressive LDL Lowering, or Better Approaches for Targeting High-Risk Individuals? | industry_news | Other Clinical Pharmacy News | 0 | 08-19-2008 01:57 PM |
© 2008 DrugManagementForum™ powered by |
 |